NYSE$MTD

Mettler-Toledo International Inc · Q1 2025 earnings

Q1 2025 earnings · · After market close · Investor relations

Briefing

Mettler-Toledo reported Q1 2025 net sales of $883.7M with net earnings of $163.6M and diluted EPS of $7.81.

Net sales declined 4.6% to $883.7 million as product revenue softened while service revenue grew modestly. Net earnings were $163.6 million versus $177.5 million a year ago; diluted EPS was $7.81. Gross margin remained strong at 59.5% of sales despite lower volumes and ongoing investments in R&D and field sales.

  • Q1 net sales $883.7M with product sales $650.0M and service $233.8M.
  • Net earnings $163.6M; diluted EPS $7.81.
  • Gross profit $525.9M; R&D and SG&A spending stable.
  • Restructuring charges declined year over year to $3.8M.
  • Laboratory and industrial instrument demand mixed by region.

Headline financials

Total Revenue

$884M

Previous: $926M-4.6%
EPS (adj)

$7.81

Previous: $8.24-5.2%
Gross Profit Margin

59.5%

Previous: 59.2%+0.5%
Adjusted Operating Profit

$237M

Previous: $267M-11.4%
Capital Expenditures

-$17.3M

Previous: -$17.4M+0.8%
Free Cash Flow

$177M

Previous: $160M+10.7%
Net Income

$164M

Previous: $178M-7.8%
Operating Income

$216M

Previous: $239M-9.9%
Gross Profit

$526M

Previous: $548M-4.1%
Total Assets

$3.23B

Previous: $3.28B-1.5%

Revenue & EPS history

Mettler-Toledo · Revenue · Quarterly

$884M

Q1 2025-4.6%vs Q1 2024
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Forward guidance

Mettler-Toledo typically updates full-year outlook on earnings calls; the 10-Q highlights focus on service growth, productivity, and pricing to offset volume headwinds in select end markets.

Tailwinds

  • Recurring service revenue provides stability.
  • Strong gross margins and pricing discipline.
  • Restructuring benefits and cost control.

Headwinds

  • Soft product demand in China and Europe industrial markets.
  • Currency translation headwinds.
  • Long sales cycles in pharma and biotech capital equipment.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2025

Historical avgQ1 2025

+0.6%

Avg return

Earnings day

-1.1%

Avg return

5 days after

+0.0%

Avg return

30 days after

59%

41 / 69 earnings

Positive

+20.5%

Q1 2024

Best reaction

-8.0%

Q4 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.6%-22.7%-12.5%
Q4 2025-0.7%+0.7%-12.5%
Q3 2025+0.0%+0.6%-1.7%
Q2 2025-3.0%-1.0%+5.5%
Q1 2025+4.0%+2.6%+9.4%
Q4 2024+2.4%-3.3%-4.8%
Q3 2024-6.3%-9.8%-10.0%
Q2 2024-5.2%-9.1%-5.4%
Q1 2024+20.5%+19.4%+14.8%
Q4 2023-3.2%-4.6%+8.3%
Q3 2023+0.6%+1.0%+5.0%
Q2 2023-2.0%-3.8%-12.0%
Q1 2023-4.5%-7.8%-10.7%
Q4 2022-2.7%-0.6%-7.8%
Q3 2022+3.7%+9.1%+20.0%
Q2 2022+6.0%+5.2%-1.7%
Q1 2022-4.6%-11.6%-5.9%
Q4 2021-8.0%-8.0%-15.7%
Q3 2021+3.2%+5.9%+4.0%
Q2 2021-0.9%+0.6%+5.2%
Q1 2021-1.1%-4.1%-2.8%
Q4 2020+0.6%+1.5%-10.8%
Q3 2020+9.3%+4.2%+4.8%
Q2 2020+4.1%+3.4%+7.6%
Q1 2020+0.6%-3.6%+20.1%
Q4 2019+1.0%+0.1%-8.1%
Q3 2019-0.1%+0.2%+7.2%
Q2 2019-5.1%-6.6%-13.2%
Q1 2019-1.7%-2.4%+6.8%
Q4 2018+1.1%+2.6%+3.9%
Q3 2018+2.6%-0.6%-0.3%
Q2 2018-3.7%-3.3%-7.3%
Q1 2018-1.4%-2.6%+1.5%
Q4 2017-6.5%-4.4%-4.0%
Q3 2017-6.3%-9.4%-9.4%
Q2 2017-3.3%-4.1%-1.2%
Q1 2017+6.0%+6.6%+16.3%
Q4 2016+6.2%+6.4%+10.6%
Q3 2016+4.8%+7.2%+2.4%
Q2 2016+5.2%+2.4%+4.7%
Q1 2016+0.7%
Q4 2015+0.8%
Q3 2015+4.7%
Q2 2015-0.0%
Q1 2015+0.9%
Q4 2014-0.5%
Q3 2014+6.9%
Q2 2014+1.8%
Q1 2014+2.2%
Q4 2013+6.8%
Q3 2013-3.4%
Q2 2013-1.1%
Q1 2013+6.2%
Q4 2012+2.5%
Q3 2012+3.3%
Q2 2012+3.1%
Q1 2012-7.9%
Q4 2011-0.4%
Q3 2011+5.7%
Q2 2011-7.6%
Q1 2010-7.6%
Q1 2011+0.7%
Q4 2008+0.8%
Q4 2010+0.8%
Q3 2010+3.1%
Q3 2009+3.1%
Q4 2009+0.9%
Q2 2010+0.9%
Q2 2009+0.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro